Guanze Medical Information Industry (Holding) Co., Ltd. (HKG:2427)
Hong Kong · Delayed Price · Currency is HKD 1.560
0.00 (0.00%)
At close: Jan 26, 2026
HKG:2427 Revenue
Guanze Medical Information Industry (Holding) had revenue of 31.86M CNY in the half year ending June 30, 2025, a decrease of -57.19%. This brings the company's revenue in the last twelve months to 147.57M, up 21.26% year-over-year. In the year 2024, Guanze Medical Information Industry (Holding) had annual revenue of 155.74M, down -0.21%.
Revenue (ttm)
147.57M CNY
Revenue Growth
+21.26%
P/S Ratio
9.17
Revenue / Employee
2.54M CNY
Employees
58
Market Cap
1.48B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 155.74M | -332.00K | -0.21% |
| Dec 31, 2023 | 156.07M | -21.04M | -11.88% |
| Dec 31, 2022 | 177.11M | -33.96M | -16.09% |
| Dec 31, 2021 | 211.08M | 26.64M | 14.44% |
| Dec 31, 2020 | 184.44M | 43.61M | 30.97% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| WuXi XDC Cayman | 5.58B |
| Adicon Holdings | 2.98B |
| Kindstar Globalgene Technology | 998.42M |
| Yunkang Group | 706.95M |
| Biosino Bio-Technology and Science Incorporation | 246.61M |
| Mega Genomics | 171.61M |
| King International Investment | 77.50M |
| China Biotech Services Holdings | 76.93M |